Protects 340B drug discount program permanently

File HF3609 ("Protects 340B drug discount program permanently") is before the Minnesota Legislature and has not been decided. Latest step (April 28, 2026): Author added.

Minnesota file HF3609, before the Minnesota Legislature. Still to be decided as of 2026-04-28.

What it does

Hospitals and clinics keep low-cost drug access indefinitely Safety-net providers, including public hospitals and federally qualified health centers, maintain ability to purchase discounted medications under the 340B program without drug makers blocking or restricting their participation.

The bigger picture

Lower-income patients benefit from sustained medication affordability By stabilizing the 340B program, hospitals and clinics serving uninsured and underinsured populations can reinvest savings from discounted drugs into patient care and community health services.

What to watch

Drug manufacturers lose pricing leverage over safety-net providers Pharmaceutical companies warn this removes their ability to negotiate terms with the 340B program or enforce distribution controls, potentially affecting their business model and pricing strategies.

Official summary

Disallowance of drug manufacturers from restricting delivery of 340B prescription drugs continued, enforcement provided, and expiration date removed.

Read the official record for HF3609

See everything up for a vote · This week in Minnesota · See what we have filed with the clerk